Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Link established between breast and ovarian cancer:

This article was originally published in Clinica

Executive Summary

Women who develop breast cancer before the age of 50 are more likely to carry BRCA1 and BRCA2 gene mutations if they have a family history of both breast and ovarian cancer, US researchers reported in the July issue of the Journal of Clinical Oncology. Breast cancer patients with these mutations are also ten times more likely to get ovarian cancer, prompting the researchers to suggest genetic testing for women diagnosed with breast cancer who have a high probability of carrying a mutation. The group was headed by Myriad Genetic Laboratories which provides BRCA1 and BRCA2 mutation testing.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts